Protagenic Therapeutics, Inc.\new (PTIX) Shares Outstanding (Entity) (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) recorded Shares Outstanding (Entity) of 1.81 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.1% from 3.7 million a year earlier and down 22.3% from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new reported Shares Outstanding (Entity) of 2.33 million, down 59.8% from FY2025.
- Annual Shares Outstanding (Entity) has a five-year compound annual growth rate of 49.9% (FY2021 to FY2026).
- Across earlier fiscal years, Shares Outstanding (Entity) came in at 5.8 million in FY2025, 5.4 million in FY2024, 316,801 in FY2023 (+2.6%) and 308,672 in FY2022 (+0.4%).
- The fiscal Q1 2027 figure is the lowest quarterly Shares Outstanding (Entity) since fiscal Q4 2015.
- Per Business Quant, the preceding three fiscal quarters came in at 2.33 million (Q4 2026), 1.93 million (Q3 2026) and 1.93 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 323,513.00 |
| Jun 30, 2024 | 319,097.00 |
| Mar 31, 2024 | 316,801.00 |
| Dec 31, 2023 | 316,801.00 |
| Sep 30, 2023 | 316,801.00 |
| Jun 30, 2023 | 309,360.00 |
| Mar 31, 2023 | 309,360.00 |
| Dec 31, 2022 | 308,672.00 |
| Sep 30, 2022 | 308,672.00 |
| Jun 30, 2022 | 308,672.00 |
| Mar 31, 2022 | 308,672.00 |
| Dec 31, 2021 | 307,321.00 |
| Sep 30, 2021 | 302,789.00 |
API Access
Protagenic Therapeutics, Inc.\new Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();